Literature DB >> 11418381

A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update.

A C Vigorito, J F Marques Júnior, F J Aranha, G B Oliveira, E C Miranda, C A De Souza.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11418381

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

Review 1.  Allogeneic transplantation: peripheral blood vs. bone marrow.

Authors:  William I Bensinger
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

Review 2.  Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies.

Authors:  Daniel Kl Cheuk
Journal:  World J Transplant       Date:  2013-12-24

3.  How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.

Authors:  Shannon R McCurdy; Leo Luznik
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

5.  Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.

Authors:  W Bensinger
Journal:  Bone Marrow Transplant       Date:  2006-09-04       Impact factor: 5.483

6.  How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.

Authors:  Shannon R McCurdy; Leo Luznik
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.